• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1616C156E
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Occlusion (1984); Pain (1994)
Date of Event 09/05/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant iis stent graft system was implanted in a patient for the endovascular treatment of an unknown size abdominal aortic aneurysm.The patient had pre-existing distal aortic narrowing with calcification.It was reported that the patient presented one week post the index procedure with leg pain, and an occluded limb was identified on ct scan.A thrombectomy with ivus and pta was carried out to resolve the occlusion.As per the physician, the cause of the event was due to the patients narrow calcified distal aorta.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Film evaluation summary: the caused of the reported limb occlusion seen one week post-implant could not be determined from the pre-implant films provided.Images during implant and post-implant were not available for review and the reported occlusion and stent graft in-vivo configuration could not be assessed.The location/side of the occlusion was also not reported.It is possible that implanting within the severely calcified and small caliber distal aorta may have led to limb compression and resulting occlusion.Other possible occlusion contributors (which are currently unknown) include limb/vessel oversizing, and if the occluded limb may have been extended into the external iliac artery.This may also have been caused by a patient condition: poor distal runoff, an unknown coagulopathy that is now presenting, or a previous history of pad.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key9004051
Report Number9612164-2019-03879
Device Sequence Number2377012
Product Code MIH
UDI-Device Identifier00643169467668
UDI-Public00643169467668
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/01/2021
Device Model NumberETLW1616C156E
Device Catalogue NumberETLW1616C156E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/05/2019
Initial Date Received by Manufacturer 09/05/2019
Supplement Date Received by Manufacturer09/30/2019
Initial Report FDA Received Date09/12/2019
Supplement Report FDA Received Date10/16/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
-
-